Effect of Continuous 6 Months Oral Antioxidant Combination with Universally recommended Dosage in Idiopathic Male Infertility

2016 ◽  
Vol 7 (1) ◽  
pp. 0-0
Author(s):  
Ratna Chattopadhyay ◽  
Shanawaz Yasmin ◽  
BN Chakravarty
Keyword(s):  
Male Infertility ◽  
Sperm Quality ◽  
Antioxidant Therapy ◽  
Recommended Dosage ◽  
Idiopathic Male Infertility ◽  
Before And After ◽  
Clinically Significant ◽  
High Level ◽  
A Prospective Study ◽  
Treatment Improvement

ABSTRACT The aim of the present study was to observe the adverse effects of high level of reactive oxygen species (ROS) in idiopathic male infertility and the role of a combined antioxidant therapy for six months to overcome the detrimental effects of ROS. A prospective study including 185 infertile male was conducted at Institute of Reproductive Medicine (IRM) from January 2014 to April 2015. All the major sperm parameters as well as ROS, antioxidant level and the effect of high ROS level were evaluated before and after the therapy. A significant improvement in sperm motility and concentration were observed after 6 months of therapy. Antioxidant level had increased and ROS level had decreased significantly after the antioxidant treatment. Improvement in morphology and leukocyte concentration were observed though not clinically significant. Conclusion This combined antioxidant therapy may improve sperm quality after continuous 6 months of treatment. However, further study is needed regarding this experiment for validating the trend. How to cite this article Chattopadhyay R, Yasmin S, Chakravarty BN. Effect of Continuous 6 Months Oral Antioxidant Combination with Universally recommended Dosage in Idiopathic Male Infertility. Int J Infertil Fetal Med 2016;7(1):1-6.

Effect of Continuous 6 Months Oral Antioxidant Combination with Universally recommended Dosage in Idiopathic Male Infertility

2016 ◽  
Vol 7 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Ratna Chattopadhyay ◽  
Shanawaz Yasmin ◽  
BN Chakravarty
Keyword(s):  
Male Infertility ◽  
Sperm Quality ◽  
Antioxidant Therapy ◽  
Recommended Dosage ◽  
Idiopathic Male Infertility ◽  
Before And After ◽  
Clinically Significant ◽  
High Level ◽  
A Prospective Study ◽  
Treatment Improvement

ABSTRACT The aim of the present study was to observe the adverse effects of high level of reactive oxygen species (ROS) in idiopathic male infertility and the role of a combined antioxidant therapy for six months to overcome the detrimental effects of ROS. A prospective study including 185 infertile male was conducted at Institute of Reproductive Medicine (IRM) from January 2014 to April 2015. All the major sperm parameters as well as ROS, antioxidant level and the effect of high ROS level were evaluated before and after the therapy. A significant improvement in sperm motility and concentration were observed after 6 months of therapy. Antioxidant level had increased and ROS level had decreased significantly after the antioxidant treatment. Improvement in morphology and leukocyte concentration were observed though not clinically significant. Conclusion This combined antioxidant therapy may improve sperm quality after continuous 6 months of treatment. However, further study is needed regarding this experiment for validating the trend. How to cite this article Chattopadhyay R, Yasmin S, Chakravarty BN. Effect of Continuous 6 Months Oral Antioxidant Combination with Universally recommended Dosage in Idiopathic Male Infertility. Int J Infertil Fetal Med 2016;7(1):1-6.

scholarly journals ANTIOXIDANT THERAPY IS THE KEY TO THE TREATMENT OF IDIOPATHIC MALE INFERTILITY

2017 ◽  
pp. 177-181
Author(s):  
R. I. Ovchinnikov ◽  
A. Yu. Popova ◽  
S. I. Gamidov ◽  
A. V. Kvasov
Keyword(s):  
Male Infertility ◽  
Antioxidant Therapy ◽  
Idiopathic Male Infertility

1367: Plasma Homocysteine as a Possible Marker for Male Infertility: Does Nutrition Influence Sperm Quality?

2005 ◽  
Vol 173 (4S) ◽  
pp. 371-371
Author(s):  
Nikolai Leonhartsberger ◽  
Kadir Tosun ◽  
Germar-Michael Pinggera ◽  
Michael Mitterberger ◽  
Peter Rehder ◽  
...  
Keyword(s):  
Male Infertility ◽  
Sperm Quality ◽  
Plasma Homocysteine

Effect of the Oestrus Cycle on Coxofemoral Joint Laxity

1997 ◽  
Vol 10 (02) ◽  
pp. 69-74 ◽  
Author(s):  
G. K. Smith ◽  
M. G. Conzemius ◽  
H. M. Saunders ◽  
C. M. Hill ◽  
T. P. Gregor ◽  
...  
Keyword(s):  
Prospective Study ◽  
Hip Dysplasia ◽  
Joint Laxity ◽  
Hormone Levels ◽  
Oestrus Cycle ◽  
Clinically Significant ◽  
A Prospective Study

SummaryA few investigations in the 1960’s were performed to document the effect of exogenous oestrogens on development of hip dysplasia. These projects concluded that oestrogen administration caused a significant increase in hip dysplasia. Additionally, the Orthopaedic Foundation for Animals (OFA) has recommended that bitches should not have hip evaluation for certification during oestrus, due to the possibility of increased coxofemoral joint laxity. The purpose of this project was to determine if physiological fluctuations of oestrogen and progesterone throughout the oestrus cycle significantly affected coxofemoral joint laxity. Nine bitches were evaluated through a single oestrus cycle. Although significant fluctuations of oestrogen and progesterone occurred throughout the phases of the oestrus cycle, neither statistically nor clinically significant changes in coxofemoral joint laxity were documented.A prospective study documented the effect of fluctuations of hormone levels throughout the oestrus cycle on coxofemoral joint laxity in nine dogs. Although oestrogen and progesterone levels changed significantly throughout the oestrus cycle, neither statistically nor clinically significant changes in hip laxity were observed.

Effect of new dietary supplement on sperm quality

2012 ◽  
Vol 153 (45) ◽  
pp. 1787-1792 ◽  
Author(s):  
Mária Horváth ◽  
Endre Czeizel
Keyword(s):  
Adverse Effect ◽  
Clinical Trial ◽  
Dietary Supplement ◽  
Male Fertility ◽  
Sperm Quality ◽  
Sperm Count ◽  
Before And After ◽  
The Usa ◽  
New Treatments

Introduction: There is a decline in male fertility thus new treatments are needed. Aims: To test the efficacy of a new dietary supplement developed in the USA and registered as a curing drug in Hungary (OGYI). Methods: In a clinical trial 100 men with low sperm quality (spermium count 5–20 M/ml, good motility 10–40%, and adverse shape 30–50%) were examined. Results: Sperm parameters were measured before and after a 3-month treatment and after another 3-month without treatment. This dietary supplement statistically and clinically significantly improved sperm count and motility. In 74 cases this dietary supplement demonstrated a beneficial effect on sperm quality (more than 10% increase in sperm count, or quality of motility, or shape); in 16 cases the improvement exceeded 30%. No adverse effect could be accounted for this treatment. Conclusions: This new dietary supplement may contribute to the treatment of male infertility. Orv. Hetil., 2012, 153, 1787–1792.

Quality of Life Before and After Endovascular and Open Repair of Asymptomatic AAAs: A Prospective Study

2000 ◽  
Vol 7 (5) ◽  
pp. 372-379 ◽  
Author(s):  
Martin Malina ◽  
Marie Nilsson ◽  
Jan Brunkwall ◽  
Krasnodar Ivancev ◽  
Timothy Resch ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prospective Study ◽  
Open Repair ◽  
Before And After ◽  
A Prospective Study

scholarly journals Treatment of HIV-associated facial lipoatrophy: impact on infection progression assessed by viral load and CD4 count

2013 ◽  
Vol 88 (4) ◽  
pp. 570-577 ◽  
Author(s):  
Flávia Machado Gonçalves Soares ◽  
Izelda Maria Carvalho Costa
Keyword(s):  
Viral Load ◽  
Disease Progression ◽  
Statistical Significance ◽  
Undetectable Viral Load ◽  
Fat Distribution ◽  
Cd4 Count ◽  
Before And After ◽  
Facial Lipoatrophy ◽  
A Prospective Study ◽  
The Impact

BACKGROUND: HIV/AIDS-Associated Lipodystrophy Syndrome includes changes in body fat distribution, with or without metabolic changes. The loss of fat from the face, called facial lipoatrophy, is one of the most stigmatizing signs of the syndrome.OBJECTIVES:To evaluate the effect of FL treatment using polymethylmethacrylate (PMMA) implants on disease progression, assessed by viral load and CD4 cell count.METHODS: This was a prospective study of 44 patients treated from July 2009 to December 2010. Male and female patients, aged over 18 years, with clinically detectable FL and who had never been treated were included in the study. PMMA implantation was done to fill atrophic areas. Laboratory tests were conducted to measure viral load and CD4 count before and after treatment.RESULTS: Of the 44 patients, 72.72% were male and 27.27% female, mean age of 44.38 years. Before treatment, 82% of patients had undetectable viral load, which increased to 88.6% after treatment, but without statistical significance (p = 0.67). CD4 count before treatment ranged from 209 to 1293, averaging 493.97. After treatment, the average increased to 548.61. The increase in CD4 count after treatment was statistically significant with p = 0.02.CONCLUSION: The treatment of FL with PMMA implants showed a statistically significant increase in CD4 count after treatment, revealing the impact of FL treatment on disease progression. Viral load before and after treatment did not vary significantly.

scholarly journals Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study

2021 ◽  
Vol 12 ◽  
pp. 204062232110052
Author(s):  
Jeremy Chambord ◽  
Lionel Couzi ◽  
Pierre Merville ◽  
Karine Moreau ◽  
Fabien Xuereb ◽  
...  
Keyword(s):  
Medication Adherence ◽  
Immunosuppressive Therapy ◽  
Medication Management ◽  
Intervention Group ◽  
Knowledge Score ◽  
Control Group ◽  
Patient Knowledge ◽  
Transplant Patients ◽  
Before And After ◽  
High Level

Aims: To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. Methods: We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG), n = 44] versus those who did not [control group (CG), n = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure. Results: At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% versus 72.2%, p = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2. Conclusions: Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.

Sign in / Sign up

Export Citation Format

Share Document